Is sleep disruption a risk factor for Alzheimer's disease?
Open accessThe DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Abstract
Sleep disturbances are routinely encountered in Alzheimer’s disease (AD) and affect about 25–40% of patients in the mild-to-moderate stages of the disease. In many, sleep pathology may represent a symptom of the underlying neurodegeneration. However, a history of sleep disruption occurring years prior to onset of cognitive symptoms could represent a potential risk factor for AD. The aim of the present narrative review was to evaluate current evidence linking sleep disturbances with AD development and to understand the mechanisms that may contribute to this. Although the mechanisms by which poor sleep may contribute to AD genesis is not fully understood, emerging evidence linking disturbances in the sleep wake cycle with Aβ deposition is shedding light on the relationship between sleep pathology and the subsequent development of AD. Aβ burden appears to be enhanced by sleep-wake cycle disruptions and is suspected as being an important mechanism by which sleep disruptions contribute in AD development. Other mechanisms triggered by sleep disruption may also be involved in AD development, such as brain hypoxia, oxidative stress, circadian activity rhythms disturbances, overexpression of orexins, and blood-brain barrier impairment. Further understanding of the link between sleep disturbances and future development of AD is still needed before sleep disturbances are clearly marked as a preventable risk factor for AD. In these circumstances, early lifestyle interventions to help increase the quantity and quality of sleep may have a favorable outcome on decreasing the incidence of AD and this needs to be investigated further.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“sleep disturbance has been linked with β-amyloid (Aβ) deposition,131, 132 reduced glymphatic clearance pathways activation,133 low grade inflammation, increased Tau, hypoxia132, 134 and cardiovascular disease.135”
From Dementia prevention, intervention, and care: 2020 report of the Lancet Commission (2020) · cites this paper as [132]
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155 · cited 1×
“The accumulation of results from an imbalance between its production and clearance, which is a key early step in the pathogenesis of AD and begins 10-20 years before the appearance of cognitive symptoms – this period is known as the preclinical stage of AD [7].”
Sleep Drives Metabolite Clearance from the Adult Brain
Xie, L., Kang, H., Xu, Q., Chen, M. J., Liao, Y., Thiyagarajan, M., O’Donnell, J., Christensen, D. J., Nicholson, C., Iliff, J. J., et al. (2013) · Science · doi:10.1126/science.1241224 · Cited by 5,411 · cited 2×
“occurs due to an alteration in the adrenergic signaling during sleep [49-52].”
The global prevalence of dementia: a systematic review and metaanalysis.
Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., & Ferri, C. P. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.11.007 · Cited by 4,941 · cited 1×
“In 2010, the number of people affected by dementia worldwide was estimated to be 35.6 million, and this figure is expected to double every 20 years [3].”
InfluentialHypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806 · cited 1×
“The main pathological hallmarks of AD are the diffuse deposition of extracellular amyloid-(cid:2) (A (cid:2) ) plaques across the brain parenchyma, the aggregation of hyperphosphorylated tau protein into intracellular neurofibrillary tangles (NFT) and neuronal loss [4–6].”
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268 · cited 1×
“Risk factors for AD include advanced age [8-10], inherited genetic mutations in three genes (AβPP, PSEN1 and PSEN2) [11-13], allele apolipoprotein E (APOE) ε4 [14-16], lack of aerobic cardiovascular exercise [17], high blood pressure [18], tobacco use [19] and hypercholesterolemia [20], among others.”
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051 · cited 2×
“Risk factors for AD include advanced age [8-10], inherited genetic mutations in three genes (AβPP, PSEN1 and PSEN2) [11-13], allele apolipoprotein E (APOE) ε4 [14-16], lack of aerobic cardiovascular exercise [17], high blood pressure [18], tobacco use [19] and hypercholesterolemia [20], among others.”
Neurons containing hypocretin (orexin) project to multiple neuronal systems
Peyron, C., Tighe, D. K., van den Pol, A. N., de Lecea, L., Heller, H. C., Sutcliffe, J. G., & Kilduff, T. S. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09996.1998 · Cited by 3,466 · cited 1×
“Orexins play a role in wakefulness maintenance and prevent undesirable transitions into sleep [61], as presented by orexin knock-out mice and narcoleptic patients [62-66].”
Forecasting the global burden of Alzheimer's disease
Brookmeyer, R., Johnson, E., Ziegler‐Graham, K., & Arrighi, H. M. (2007) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2007.04.381 · Cited by 3,370 · cited 1×
“Risk factors for AD include advanced age [8-10], inherited genetic mutations in three genes (AβPP, PSEN1 and PSEN2) [11-13], allele apolipoprotein E (APOE) ε4 [14-16], lack of aerobic cardiovascular exercise [17], high blood pressure [18], tobacco use [19] and hypercholesterolemia [20], among others.”
Narcolepsy in orexin Knockout Mice
Chemelli, R. M., Willie, J. T., Sinton, C. M., Elmquist, J. K., Scammell, T., Lee, C., Richardson, J. A., Williams, S. C., Xiong, Y., Kisanuki, Y., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81973-x · Cited by 3,095 · cited 1×
“Orexins play a role in wakefulness maintenance and prevent undesirable transitions into sleep [61], as presented by orexin knock-out mice and narcoleptic patients [62–66].”
Cited by
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30367-6 · Cited by 10,430
“Mechanisms by which sleep might affect dementia remain unclear, but sleep disturbance has been linked with β-amyloid (Aβ) deposition, 131,132 reduced glymphatic clearance pathways activation, 133 low grade inflammation, increased Tau, hypoxia 132,134 and cardiovascular disease.”
RetractedGlymphatic System Impairment in Alzheimer’s Disease and Idiopathic Normal Pressure Hydrocephalus
Reeves, B. C., Karimy, J. K., Kundishora, A. J., Mestre, H., Cerci, H. M., Matouk, C., Alper, S. L., Lundgaard, I., Nedergaard, M., & Kahle, K. T. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.11.008 · Cited by 403
“The critical importance of glymphatic function on brain health and its functional dependence on sleep suggests that sleep dysfunction may not only accelerate the progression of dementia, but may itself be a risk factor for dementia development [84].”
BackgroundHerring, W. J., Ceesay, P., Snyder, E., Bliwise, D., Budd, K., Hutzelmann, J., Stevens, J., Lines, C., & Michelson, D. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12035 · Cited by 185
Cimenser, A., Hempel, E., Travers, T., Strozewski, N., Martin, K., Malchano, Z., & Hajós, M. (2021) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2021.746859 · Cited by 107
“In line with these observations, recent experimental and epidemiological findings demonstrate that sleep disorders represent a risk for developing AD, and a close correlation exists between sleep abnormalities and decline in activities of daily living of AD patients (Macedo et al., 2017; Hennawy et al., 2019; Bubu et…”
BackgroundResultStructural brain correlates of obstructive sleep apnoea in older adults at risk for dementia
Cross, N. E., Memarian, N., Duffy, S. L., Paquola, C., LaMonica, H. M., D'Rozario, A. L., Lewis, S. J. G., Hickie, I. B., Grunstein, R. R., & Naismith, S. L. (2018) · European Respiratory Journal · doi:10.1183/13993003.00740-2018 · Cited by 103
Wong, R., & Lovier, M. A. (2023) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2023.01.008 · Cited by 90
Hoyt, K. R., & Obrietan, K. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00537-9 · Cited by 77
Arterial vasodilation drives convective fluid flow in the brain: a poroelastic model
Kedarasetti, R. T., Drew, P. J., & Costanzo, F. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00326-y · Cited by 67
A New Hypothesis for Alzheimer’s Disease: The Lipid Invasion Model
Rudge, J. D. (2022) · Journal of Alzheimer's Disease Reports · doi:10.3233/adr-210299 · Cited by 58
“Questions about how so many diverse lifestyle risk factors for AD (hypertension [24], obesity [25–27], diabetes [28], smoking [29], stress [30], sleep deprivation [31], and head injury [32]) can all promote AD by increasing A levels.”
BackgroundNeuroendocrine Control of Sleep
Smith, P. C., & Mong, J. A. (2019) · Current topics in behavioral neurosciences · doi:10.1007/7854_2019_107 · Cited by 48
“Additionally, self-reported sleep problems, most notably sleep fragmentation, have been associated with a higher risk of Alzheimer’s years later (Macedo et al. 2017).”
BackgroundDefining novel functions for cerebrospinal fluid in ALS pathophysiology
Kwong, K. C. N. K., Mehta, A. R., Nedergaard, M., & Chandran, S. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01018-0 · Cited by 43
Wu, M., Zhou, F., Cao, X., Yang, J., Bai, Y., Yan, X., Cao, J., & Qi, J. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.04.008 · Cited by 36
ENIGMA‐Sleep: Challenges, opportunities, and the road map
Tahmasian, M., Aleman, A., Andreassen, O. A., Arab, Z., Baillet, M., Benedetti, F., Bresser, T., Bright, J. K., Chee, M. W. L., Chylinski, D., et al. (2021) · Journal of Sleep Research · doi:10.1111/jsr.13347 · Cited by 35
Orexin and Alzheimer’s Disease: A New Perspective
Um, Y. H., & Lim, H. K. (2020) · Psychiatry Investigation · doi:10.30773/pi.2020.0136 · Cited by 35
Rostampour, M., Noori, K., Heidari, M., Fadaei, R., Tahmasian, M., Khazaie, H., & Zarei, M. (2020) · Sleep Medicine · doi:10.1016/j.sleep.2020.06.024 · Cited by 31
Predicting Alzheimer's disease CSF core biomarkers: a multimodal Machine Learning approach
Gaeta, A. M., Quijada-López, M., Barbé, F., Vaca, R., Pujol, M., Mínguez, O., Sánchez‐de‐la‐Torre, M., Muñoz‐Barrutia, A., & Piñol‐Ripoll, G. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1369545 · Cited by 33
Howard, C., Mukadam, N., Hui, E. K., & Livingston, G. (2024) · Sleep Medicine · doi:10.1016/j.sleep.2024.10.022 · Cited by 30
“Nevertheless, most research examining the relationship between sleep duration and dementia incidence is cross-sectional [30], with few longitudinal studies [2,8,30,32].”
Balouch, S., Dijk, D. A. D., Rusted, J. M., Skene, S. S., Tabet, N., & Dijk, D. (2022) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12303 · Cited by 24
Self-citationAhnaou, A., & Drinkenburg, W. H. I. M. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.039 · Cited by 26
Effect of a dual orexin receptor antagonist on Alzheimer's disease: Sleep disorders and cognition
Zhou, M., & Tang, S. H. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2022.984227 · Cited by 32
“Long-term sleep disorders and insufficient sleep will cause one or more cognitive function impairments, affecting daily life and social ability (2).”
BackgroundHe, Y., Li, Y., Zhou, F., Qi, J., & Wu, M. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-00531-z · Cited by 21
Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptoms
Vuić, B., Milos, T., Tudor, L., Perković, M. N., Konjevod, M., Erjavec, G. N., Farkaš, V., Uzun, S., Mimica, N., & Štrac, D. Š. (2023) · Genes · doi:10.3390/genes14112048 · Cited by 19
“Moreover, people with dementia often experience sleep problems such as insomnia, impaired nocturnal sleep with increased awakenings, and decreased rapid eye movement (REM) sleep, as well as increased daytime sleep [272,273].”
BackgroundCassar, M., Law, A. D., Chow, E. S., Giebultowicz, J. M., & Kretzschmar, D. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00232 · Cited by 16
“…several studies have suggested a link between the accumulation of plaque-associated β-amyloid and sleep (Brown et al., 2016; Cedernaes et al., 2017; Macedo et al., 2017; Yulug et al., 2017), a role of neuropathic forms of Tau in disrupting sleep has only recently been addressed (Holth et al.,…”
BackgroundBriggs, R., Kennelly, S., & O’Neill, D. J. (2019) · Springer eBooks · doi:10.1007/978-3-030-06200-2_15 · Cited by 12
Ficiarà, E., Stura, I., Vernone, A., Silvagno, F., Cavalli, R., & Guiot, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042337 · Cited by 12
“It is a multifactorial pathology, linking population risk factors, e.g., nanopollution [1], sleep disruption [2], or even bacterial infections [3,4].”
BackgroundLi, H., Tsai, M., Huang, C., Wang, R., Chuang, L., Chen, N., Liu, C., Hsu, C., Cheng, W., & Lee, L. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091361 · Cited by 11
“Furthermore, the potential pathways and causal relationships between OSA and AD have yet to be established [7].”
BackgroundMo, W., Liu, X., Yamakawa, M., Koujiya, E., Takeya, Y., Shigenobu, K., Adachi, H., & Ikeda, M. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.116067 · Cited by 15
Repairing blood-CNS barriers: Future therapeutic approaches for neuropsychiatric disorders
Bicker, J., Alves, G., Fonseca, C., Falcão, A. C., & Fortuna, A. C. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105226 · Cited by 11
Adiponectin improves amyloid‐β 31‐35‐induced circadian rhythm disorder in mice
Yuan, Y., Li, C., Guo, S., Sun, C., Ning, N., Hao, H., Wang, L., Bian, Y., Liu, H., & Wang, X. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16932 · Cited by 9
Filipović, B. F., Đurić, V., Filipović, N., Kiurski, S., Kiswani, J. A., Marković, B., Laketić, D., Marjanovic-Haljilji, M., Kapor, S., & Filipović, B. (2021) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2021/8873652 · Cited by 9
Gaggi, N. L., Parincu, Z., Peterson, A., O’Brien, C., Kam, K., Tural, Ü., Ayappa, I. A., Varga, A. W., Iosifescu, D. V., & Osorio, R. S. (2025) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2025.1542462 · Cited by 6
“There has also been evidence that sleep disordered breathing, and disrupted sleep may affect the age of onset for cognitive decline and may serve as a risk factor for AD (Osorio et al., 2015; Macedo et al., 2017).”
Bibliometric review on sleep and Alzheimer disease between 1986 and 2023
Sun, X., He, C., & Qu, H. (2023) · Medicine · doi:10.1097/md.0000000000035764 · Cited by 5
Giménez‐Llort, L., Santana-Santana, M., Ratia, M., Pérez, B., Camps, P., Muñoz‐Torrero, D., Badía, A., & Clos, M. V. (2021) · Brain Sciences · doi:10.3390/brainsci11040426 · Cited by 4
Zheng, L., Wang, Z., Liu, Y., Liu, H., Zheng, Y., Zhao, J., & Huang, S. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s388832 · Cited by 2
Smith, P. C., Cusmano, D. M., Viechweg, S. S., Schwartz, M. D., & Mong, J. A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.29.223669 · Cited by 3
An Overview on Dementia: A Major Symptom of Alzheimer's Disease
Kaur, J., Melkani, I., Singh, A., Singh, A. P., & Bala, K. (2022) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v12i4.5445 · Cited by 2
Danish, M., Dratva, M. A., Lui, K. K., Heyworth, N. C., Wang, X., Malhotra, A., Hartman, S. J., Lee, E., Sundermann, E. E., & Banks, S. J. (2024) · The International Journal of Aging and Human Development · doi:10.1177/00914150241255888 · Cited by 1
Correlation of Alzheimer’s Disease and Other Psychological and Non-Psychological Conditions
Boiko, D. I., Zhyvotovska, L. V., Боднарь, Л. А., Rud, V. O., Vasylyeva, G. Y., & Skrypnikov, A. M. (2024) · Springer eBooks · doi:10.1007/978-981-96-0259-9_5 · Cited by 2
Assessment with Non-Cognitive Screening Instruments
Larner, A. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-75259-4_5 · Cited by 1
Förstl, H., & Förstl, S. (2021) · Springer Reference Pflege, Therapie, Gesundheit · doi:10.1007/978-3-662-62426-5_58 · Cited by 1
Behavioral Presentations of Insomnia
Narizhnaya, M., & Ebben, M. R. (2022) · Springer eBooks · doi:10.1007/978-981-16-0123-1_11 · Cited by 1
Förstl, H., & Förstl, S. (2020) · Springer Reference Pflege, Therapie, Gesundheit · doi:10.1007/978-3-662-55793-8_58-1 · Cited by 2
The casual relationship between AD and sleep disorders
Wang, X., & Wu, D. (2022) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v8i.1147
Lozano-Tovar, S., Monroy‐Jaramillo, N., & Rodríguez‐Agudelo, Y. (2022) · Revista chilena de neuro-psiquiatría · doi:10.4067/s0717-92272022000300313 · Cited by 1
Disruptions of Circadian Rhythms and Sleep/Wake Cycles in Neurologic Disorders
Walker, W. H., Liu, J. A., & Nelson, R. J. (2023) · Healthy ageing and longevity · doi:10.1007/978-3-031-22468-3_22 · Cited by 1
Schmid, G., Schneeweiss, P., Hirtl, R., Kainz, J., Sauter, C., Danker‐Hopfe, H., & Dorn, H. (2025) · Bioelectromagnetics · doi:10.1002/bem.70022
“Sleep disorders are also considered a risk factor and one of the possible causes of AD (Bubu et al. 2017; Macedo et al. 2017).”
Kedarasetti, R. T., Drew, P. J., & Costanzo, F. (2022) · Figshare · doi:10.6084/m9.figshare.19771061
Moulahi, A., Maâroufi, K., Grami, D., Khadhraoui, Y., & Sebaï, H. (2026) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02465-x
“Final iron levels were expressed as micrograms of iron per gram of fresh tissue (µg/g), normalized to sample weight and dilution volume (Ficarra et al. 2024; Zhang et al. 2021; Macedo et al. 2017).”
Claffey, P., Briggs, R., Kennelly, S., & O’Neill, D. J. (2026) · Springer eBooks · doi:10.1007/978-3-032-21928-2_15
Metadata
- Authors
- Macedo, A. C., Balouch, S., & Tabet, N.
- Affiliations
- University of Sussex (GB)
- Brighton and Sussex Medical School (GB)
- Corresponding author
- Balouch, Sara
- Venue
- Journal of Alzheimer’s Disease
- Publisher
- SAGE Publications
- Published
- 2017-05-26
- Volume
- 58
- Issue
- 4
- Pages
- 993-1002
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W2618941905
- Cited by
- 49
- References
- 122
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 6 · 2023: 5 · 2022: 10 · 2021: 7 · 2020: 10 · 2019: 4 · 2018: 3
- FWCI
- 0.71
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Licence
- cc-by
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Sussex Research Online (University of Sussex) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- University of Brighton Repository (University of Brighton) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
- Keywords
- sleep disruption, Alzheimer's disease
- MeSH terms
- Orexins, Alzheimer Disease, Blood-Brain Barrier, Circadian Rhythm, Humans, Risk Factors, Sleep Wake Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.